Quick Heal Technologies Limited , a prominent player in the cybersecurity sector, has announced a significant change in its board composition and committee leadership. The company has seen the departure of a key independent director and subsequent reorganization of its committee structure.

Completion of Tenure

Ms. Apurva Joshi, who served as an Independent Woman Director for Quick Heal Technologies Limited, completed her second term on September 23, 2025. Her tenure, spanning five years, came to an end as per the company's governance structure.

Committee Positions Vacated

With the conclusion of her term, Ms. Joshi relinquished several crucial committee positions within the company:

• Chairperson of the Nomination and Remuneration Committee
• Chairperson of the Risk Management Committee
• Chairperson of the Corporate Social Responsibility Committee
• Member of the Stakeholder Relationship Committee
• Member of the Audit Committee

New Appointments

To ensure continuity in corporate governance, the Board of Quick Heal Technologies has appointed Mr. Kamal Kumar Agarwal to fill the positions vacated by Ms. Joshi. Effective September 24, 2025, Mr. Agarwal will assume the following roles:

• Chairperson of the Risk Management Committee
• Chairperson of the Corporate Social Responsibility Committee
• Member of the Audit Committee
• Member of the Nomination and Remuneration Committee
• Member of the Stakeholders Relationship Committee

Ms. Joshi's Broader Influence

It's worth noting that Ms. Apurva Joshi's expertise extends beyond Quick Heal Technologies. She currently holds independent director positions in six other listed companies:

1. Precision Camshafts Limited
2. Eleganz Interiors Limited
3. Paramount Speciality Forgings Limited
4. Fidel Softech Limited
5. Associated Alcohols & Breweries Limited
6. Covidh Technologies Limited

In these companies, particularly in Precision Camshafts Limited, Eleganz Interiors Limited, and Associated Alcohols & Breweries Limited, she serves on various committees, including Audit, Nomination & Remuneration, and Corporate Social Responsibility Committees.

Compliance and Disclosure

Quick Heal Technologies has made this announcement in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company's Compliance Officer, Vikram Dhanani, has duly informed the stock exchanges of this development, ensuring transparency and adherence to regulatory requirements.

This transition marks a significant change in Quick Heal Technologies' leadership structure, potentially influencing the company's governance and strategic direction in the coming years.

Quick Heal Technologies Limited , a prominent player in the cybersecurity software sector, has announced the departure of its Chief Executive Officer (CEO), Vishal Salvi. The company confirmed that Salvi's resignation became effective on August 31, 2025, following an earlier announcement made on July 9, 2025.

Resignation Details

Vishal Salvi, who also held the position of Key Managerial Personnel within the company, cited his intention to pursue an alternative career path as the reason for his departure. This move marks a significant change in Quick Heal's leadership structure.

Regulatory Compliance

In adherence to regulatory requirements, Quick Heal Technologies has provided the necessary disclosures to the stock exchanges. The company has complied with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, ensuring transparency in its corporate governance practices.

Company's Response

Quick Heal has attached Salvi's resignation letter to their stock exchange filing, demonstrating their commitment to keeping shareholders and the market informed. The company's prompt disclosure aligns with the best practices in corporate communication and regulatory compliance.

Looking Ahead

As Quick Heal Technologies navigates this transition in leadership, the cybersecurity industry will be watching closely to see how the company adapts and who will step into the role vacated by Vishal Salvi. The departure of a key executive often signals a period of change for a company.

While the immediate impact of this change on Quick Heal's operations and market position remains to be seen, the company's adherence to proper disclosure procedures indicates a commitment to maintaining investor trust during this transition period.

Stakeholders and industry observers will likely be keen to learn about Quick Heal's succession plans and any potential shifts in corporate strategy that may follow this leadership change.